The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice
Authors
Keywords
-
Journal
EBioMedicine
Volume 94, Issue -, Pages 104713
Publisher
Elsevier BV
Online
2023-07-21
DOI
10.1016/j.ebiom.2023.104713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
- (2023) Pablo Bascuñana et al. Biomolecules
- Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P 1 ‐selective modulation
- (2022) Yasuyuki Kihara et al. FASEB JOURNAL
- Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
- (2022) Steven G. Fagan et al. MOLECULAR NEUROBIOLOGY
- FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4
- (2022) Simone M. Crivelli et al. BIOMEDICINE & PHARMACOTHERAPY
- Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
- (2022) Linyu Wu et al. MEDIATORS OF INFLAMMATION
- Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis
- (2022) Amal Alnaif et al. ANNALS OF PHARMACOTHERAPY
- Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer’s disease
- (2022) Younghun Jung et al. BRAIN RESEARCH
- Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis
- (2021) Dawn W. Langdon et al. EUROPEAN JOURNAL OF NEUROLOGY
- Ponesimod protects against neuronal death by suppressing the activation of A1 astrocytes in early brain injury after experimental subarachnoid hemorrhage
- (2021) Lifang Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Fingolimod loaded niosomes attenuates sevoflurane induced cognitive impairments
- (2021) Hongliang Weng et al. BIOMEDICAL MICRODEVICES
- CD8 T cells and STAT1 signaling are essential co-determinants in protection from polyomavirus encephalopathy
- (2020) Taryn E. Mockus et al. JOURNAL OF VIROLOGY
- FTY720 Modulates Microglia Toward Anti-inflammatory Phenotype by Suppressing Autophagy via STAT1 Pathway
- (2020) Zi-Wei Hu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model
- (2020) Georgia-Ioanna Kartalou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain
- (2019) Zhoumou Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT1 drives M1 microglia activation and neuroinflammation under hypoxia
- (2019) Elena Butturini et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- S1P1 Regulates M1/M2 Polarization toward Brain Injury after Transient Focal Cerebral Ischemia
- (2019) Bhakta Prasad Gaire et al. Biomolecules & Therapeutics
- STAT6 mediates the effect of ethanol on neuroinflammatory response in TBI
- (2019) Florian olde Heuvel et al. BRAIN BEHAVIOR AND IMMUNITY
- Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
- (2019) Isabel Carreras et al. Scientific Reports
- S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK
- (2019) Arjun Sapkota et al. Scientific Reports
- TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer’s Disease and in Response to Hippocampal Deafferentation in Rodents
- (2018) Justin Miron et al. JOURNAL OF ALZHEIMERS DISEASE
- Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia
- (2018) Sinead A. O'Sullivan et al. JOURNAL OF NEUROCHEMISTRY
- Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
- (2018) Tanuja Chitnis et al. NEW ENGLAND JOURNAL OF MEDICINE
- TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia
- (2018) Ji-Won Lee et al. Autophagy
- Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide
- (2018) Liansheng Zhong et al. GLIA
- FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation
- (2017) Róisín M. McManus et al. Journal of Neuroimmune Pharmacology
- Aging and amyloid β oligomers enhance TLR4 expression, LPS-induced Ca2+ responses, and neuron cell death in cultured rat hippocampal neurons
- (2017) María Calvo-Rodríguez et al. Journal of Neuroinflammation
- Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells
- (2017) Alejandra Mendoza et al. NATURE
- FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits
- (2017) Alexander M. Stessin et al. NEUROSCIENCE LETTERS
- Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway
- (2017) Chuan Qin et al. STROKE
- Toll-Like Receptor 4 Is Essential for the Expression of Sphingosine-1-Phosphate-Dependent Asthma-Like Disease in Mice
- (2017) Fiorentina Roviezzo et al. Frontiers in Immunology
- Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse
- (2016) Michael B. Dinkins et al. JOURNAL OF NEUROSCIENCE
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons
- (2014) Labchan Rajbhandari et al. GLIA
- Export of sphingosine-1-phosphate and cancer progression
- (2014) Kazuaki Takabe et al. JOURNAL OF LIPID RESEARCH
- An update on the biology of sphingosine 1-phosphate receptors
- (2014) Victoria A. Blaho et al. JOURNAL OF LIPID RESEARCH
- Linking STAT and TLR signaling in microglia: a new role for the histone demethylase Jmjd3
- (2014) Uwe-Karsten Hanisch JOURNAL OF MOLECULAR MEDICINE-JMM
- Sphingolipid metabolites in inflammatory disease
- (2014) Michael Maceyka et al. NATURE
- c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
- (2014) A Sclip et al. Cell Death & Disease
- Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1receptor modulator, in the first-in-human study
- (2013) Patrick Brossard et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology
- (2013) Frederick A. Schmitt et al. Current Alzheimer Research
- IL-33 Markedly Activates Murine Eosinophils by an NF- B-Dependent Mechanism Differentially Dependent upon an IL-4-Driven Autoinflammatory Loop
- (2013) C. Bouffi et al. JOURNAL OF IMMUNOLOGY
- Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes
- (2012) Ruben van Doorn et al. ACTA NEUROPATHOLOGICA
- Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
- (2011) Adam D Bachstetter et al. Journal of Neuroinflammation
- Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient
- (2010) Jeremy Adler et al. CYTOMETRY PART A
- Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways
- (2010) Roser Gorina et al. GLIA
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid 1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
- (2008) K. L. Richard et al. JOURNAL OF NEUROSCIENCE
- CD45RB Is a Novel Molecular Therapeutic Target to Inhibit Aβ Peptide-Induced Microglial MAPK Activation
- (2008) Yuyan Zhu et al. PLoS One
- p38 Kinase Is Activated in the Alzheimer's Disease Brain
- (2003) Kenneth Hensley et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now